EDGAR Filing Documents for 0001279569-10-000465

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001279569-10-000465

Filing Date

2010-04-15

Accepted

2010-04-14 17:47:47

Documents

Period of Report

2010-02-28

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	lorus6k.htm	6-K	16186
2	NEWS RELEASE DATED APRIL 14, 2010	ex991.htm	EX-99.1	93821
3	Q3 INTERIM FINANCIAL STATEMENTS	ex992.htm	EX-99.2	498342
4	Q3 MANAGEMENT DISCUSSION AND ANALYSIS	ex993.htm	EX-99.3	215499
5	SUPPLEMENTARY INFORMATION	ex994.htm	EX-99.4	721724
6	CEO/CFO CERTIFICATES	ex995.htm	EX-99.5	37122
7	GRAPHIC	loruslogo.jpg	GRAPHIC	11681
	Complete submission text file	0001279569-10-000465.txt		1600590

Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7

Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7

LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 10750281
SIC: 2836 Biological Products, (No Diagnostic Substances)